Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orchard Supply Hardware Stores Corp (OSH), Telular Corporation (WRLS), Conceptus, Inc. (CPTS) Among Monday’s Price Gainers

Editor’s note: Related tickers: Orchard Supply Hardware Stores Corp (NASDAQ:OSH), Telular Corporation (NASDAQ:WRLS), Conceptus, Inc. (NASDAQ:CPTS), Galectin Therapeutics Inc. (NASDAQ:GALT), Medidata Solutions Inc (NASDAQ:MDSO)

Usually, if a stock starts the week with some good news, after which it gains ground in terms of share price, it keeps up its position as a top gainer during the week. That’s why it is important to take a look at the top gainers on Monday and understand why this or that stock is advancing and try to figure out whether it will continue to grow over the week. On Monday the top five price gainers are: Orchard Supply Hardware Stores Corp (NASDAQ:OSH), Telular Corporation (NASDAQ:WRLS), Conceptus, Inc. (NASDAQ:CPTS), Galectin Therapeutics Inc. (NASDAQ:GALT), and Medidata Solutions Inc (NASDAQ:MDSO)

Medidata Solutions Inc (NASDAQ:MDSO)

Orchard Supply Hardware Stores Corp (NASDAQ:OSH) surged by 50.34% to $2.24 in turnover worth about $340,000. On Friday, Orchard Supply Hardware Stores Corp (NASDAQ:OSH) said in a press release on its website that it expects comparable store sales for the first quarter (which ends on May 4) to grow by between 9.0% to 11.0%. Also, Orchard Supply Hardware Stores Corp (NASDAQ:OSH) mentioned that it got a extension until June 30 to come to an agreement with term loan lenders.

Telular Corporation (NASDAQ:WRLS) advanced by 30.63% to 12.58 in deals worth almost $1.1 million. A press release issued today on the company’s website stated that Telular Corporation (NASDAQ: WRLS) and Avista Capital Partners have reached a definitive agreement under which Avista will acquire Telular Corporation (NASDAQ:WRLS) at a price of $12.61 in cash and about $18.5 million in assumed net debt, total consideration amounts to $253 million. “This announcement represents a very positive event for our shareholders, […] We are proud of our nineteen years as a public company, during which we believe we have served our shareholders well, and the partnership with Avista will allow the Company to expand and build on its success to date. For our customers, we will continue to deliver the best remote wireless monitoring and tracking solutions available in the markets we serve,” the statement quoted Telular Corporation (NASDAQ:WRLS)’s CEO Joe Beatty.

In deals worth $12.8 million, Conceptus, Inc. (NASDAQ:CPTS), jumped 19.46% to $30.94. Today Conceptus, Inc. (NASDAQ:CPTS) posted its first quarter results, which showed a total revenue of $34.1 million (a 17.5% increase over the year). At the same time, the net income totalled to $1.9 million, against a loss of $28 million a year ago. Also today, Conceptus, Inc. (NASDAQ:CPTS) said in a press release that it has reached a definitive merger agreement with Germany-based Bayer HealtCare LLC. The transaction estimates the value of Conceptus, Inc. (NASDAQ:CPTS) at some $1.1 billion ($31.0 per share in cash).

Galectin Therapeutics Inc. (NASDAQ:GALT) gained 16.39% to $4.83 in deals worth some $205,600. The company posted today some positive news about GR-MD-02 and GM-CT-01 drugs that inhibit galectin proteins. In a press release the company said that these drugs were discovered to reverse the most advanced stage of cirrhosis.

Medidata Solutions Inc (NASDAQ:MDSO) is the fifth-highest gainer, adding 14.30% to $61.79 in turnover worth almost $214,700. Today, Medidata Solutions Inc (NASDAQ:MDSO) posted its financial results for the first quarter of 2013. Total revenues of the company increased by 26% on the year to $63.3 million, the company said in a statement.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!